Stroke Risk After COVID-19 Bivalent Vaccination in US Older Adults
This self-controlled case series evaluates stroke risk after administration of either brand of the COVID-19 bivalent vaccine, either brand of the COVID-19 bivalent plus a high-dose or adjuvanted influenza vaccine on the same day, and a high-dose or adjuvanted influenza vaccine in Medicare beneficiaries aged 65 years or older.
Source: JAMA - Category: General Medicine Source Type: research
More News: Covid Vaccine | COVID-19 | General Medicine | Influenza | Influenza Vaccine | Medicare | Stroke | Vaccines